Disclosures for "Patient Preferences of Sodium Oxybate Treatment for Narcolepsy: RESTORE End-of-Study Survey Data"
-
Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Bioscience. The institution of Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Inspire. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Inspire. The institution of Dr. Roy has received research support from Jazz . The institution of Dr. Roy has received research support from Inspire. The institution of Dr. Roy has received research support from Avadel.
-
Dr. Hudson has nothing to disclose.
-
Dr. Santamaria has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avadel,. Dr. Santamaria has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz . Dr. Santamaria has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel. Dr. Santamaria has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz .
-
Dr. Abaluck has received personal compensation for serving as an employee of avadel pharmaceuticals. Dr. Abaluck has received research support from apnimed, harmony, vanda, idorsia, avadel.
-
Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.